The excitement and enthusiasm for the New Year brings with it new thoughts and innovative promises for pioneering avenues of drug discovery and new treatment strategies for a host of disorders. Such thinking is not only optimistic, but also necessary considering the economic costs healthcare brings to any country. For example, the US devotes approximately 16% of the gross domestic product to healthcare, and spending for each individual in the US exceeds $7,000, a level that is the highest in the world. Yet, it is clear that monetary contributions alone do not offer the most effective healthcare to foster survival for individuals. For example, life expectancy in years in the US equals 78.1 years. Yet, this life expectancy trails behind other developed countries. If one compares the US to Japan, this country expends 8% of the gross domestic product on healthcare, allots approximately $2,500 for each citizen, and exceeds the life expectancy in the US by 4.5 years. Of course, many factors play a role in these statistics as well as cultural and life style differences. The US is ranked as having the highest level of obesity in the population at 34.3% while countries such as Japan have a 3.4% level of obesity. Differences in population characteristics can then yield changes in the prevalence of a specific disease for a particular country, such as leading to more individuals with diabetes mellitus in one country versus another and subsequently raising healthcare costs with an associated diminished life expectancy.
